Biognostik是一家成立于1991年的高技术公司, 致力于核酸合成的基因表达抑制剂和诊断试剂的研究, 目前集中发展基于R.A.D.A.R.®软件的治疗性反义寡聚核苷酸的研究. Biognostik是世界上最早的高品质反义序列, 原位杂交探针和相关定制设计的供应商, 公司的即用试剂盒能够快速方便的进行基因功能分析和药靶鉴定. 反义寡聚脱氧核酸是有着巨大前景的治疗工具, Antisense Pharm公司目前正运用Biognostik的反义序列进行临床前和临床实验. Biognostik独有的序列设计技术为世界各地的科学家提供了巨大的帮助, 目前有超过260篇的文献在医学和药学领域使用了Biognostik的寡聚核酸而获得了优秀的结果, 这表明Biognostik公司序列设计技术的成功. Biognostik为医药公司提供专业的服务, 实质性地加速蛋白功能分析, 药靶鉴定和药物研究的进程.
公司主要产品如下：
|
类别 |
功能 |
|
反义试剂盒（Antisense kits） |
培养细胞及体内细胞蛋白knock-down |
|
RNA i试剂盒（RNA i kits） |
高度特异性基因沉默 |
|
杂交探针试剂盒（Hybriprobe kits） |
非放射性原位杂交 |
Biognostik was founded in 1991 as a technology-driven company, focussing on the development of inhibitors and diagnostics of gene expression, primarily based on synthetic nucleic acids.
Our research efforts center around the .R.A.D.A.R.® software-based development of therapeutic ANTISENSE oligonucleotides.
Biognostik is the world's foremost supplier of custom-designed, high-quality ANTISENSE sequences and HybriProbes™ for in situ hybridization. Our ready-to-use kits enable a fast and convenient gene function analysis and drug target validation.
ANTISENSE ODNs have been shown to have a great potential as therapeutic agents. Antisense Pharma, a german biotech company currently develops some Biognostik's ANTISENSE sequences in pre-clinical and clinical trials.
Scientists from all over the world have profited greatly from Biognostik's unique sequence design expertise. Our reference list includes a selection of more than 260 publications presenting exellent results obtained with Biognostik's ODNs in a broad range of medical and pharmaceutical applications. This illustrates the success of our sequence design technology.
Biognostik offers specialized services to pharmaceutical companies to substantially speed up protein function analysis, drug target validation and drug development.
|
